Mesalazine-induced myopericarditis: a case series

BACKGROUND: Inflammatory bowel diseases (IBD) are characterized by chronic inflammation of the gastrointestinal tract but can have multiorgan involvement. Mesalazine (5-ASA) is a key therapeutic agent in IBD. Mesalazine has rare but potentially life-threatening side effects such as cardiac injury. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrei, Valentina, D’Ettore, Nicoletta, Scheggi, Valentina, di Mario, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504860/
https://www.ncbi.nlm.nih.gov/pubmed/37719002
http://dx.doi.org/10.1093/ehjcr/ytad424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504860/
https://www.ncbi.nlm.nih.gov/pubmed/37719002
http://dx.doi.org/10.1093/ehjcr/ytad424

Ejemplares similares